Regulation of system xc- in the SOD1-G93A mouse model of ALS

Experimental Neurology

Volumn 250, Issue , 2013, Pages 69-73

  Albano, Rebecca ^a   Liu, XiaoQian ^a   Lobner, Doug ^a  

^a MARQUETTE UNIVERSITY   (United States)

Author keywords

Amyotrophic lateral sclerosis; Cystine; Excitotoxicity; Glutamate; Oxidative stress; System xc

Indexed keywords

ANTIPORTER; ASPARTIC ACID; CYSTEINE ANTIPORTER; CYSTINE; EXCITATORY AMINO ACID TRANSPORTER; GLUTAMATE ANTIPORTER; GLUTAMIC ACID; SALAZOSULFAPYRIDINE; UNCLASSIFIED DRUG;

AMINO ACID TRANSPORT; AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; EXCITOTOXICITY; EXTRACELLULAR SPACE; MALE; MOUSE; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN FUNCTION; SPINAL CORD; UPREGULATION;

ALS; AMYOTROPHIC LATERAL SCLEROSIS; CYSTINE; DL-THREO-Β-BENZYLOXYASPARTIC ACID; EAAT; EXCITATORY AMINO ACID TRANSPORTER; EXCITOTOXICITY; GLIAL GLUTAMATE TRANSPORTER 1; GLT-1; GLUTAMATE; OXIDATIVE STRESS; SOD-1; SSZ; SULFASALAZINE; SUPEROXIDE DISMUTASE 1; SYSTEM X(C)-; TBOA;

AMINO ACID TRANSPORT SYSTEMS, ACIDIC; AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; DISEASE MODELS, ANIMAL; EXCITATORY AMINO ACID TRANSPORTER 1; FEMALE; GENOTYPE; HUMANS; MALE; MICE; MICE, TRANSGENIC; SPINAL CORD;

EID: 84885336241     PISSN: 00144886     EISSN: 10902430     Source Type: Journal    
DOI: 10.1016/j.expneurol.2013.09.008     Document Type: Article

References (40)

1. Alexianu M.E., Ho B.K., Mohamed A.H., La Bella V., Smith R.G., Appel S.H. The role of calcium-binding proteins in selective motoneuron vulnerability in amyotrophic lateral sclerosis. Ann. Neurol. 1994, 36:846-858.
2. Andreassen O.A., Dedeoglu A., Klivenyi P., Beal M.F., Bush A.I. N-Acetyl-l-cysteine improves survival and preserves motor performance in an animal model of familial amyotrophic lateral sclerosis. Neuroreport 2000, 11:2491-2493.
3. Bendotti C., Tortarolo M., Suchak S.K., Calvaresi N., Carvelli L., Bastone A., Rizzi M., Rattray M., Mennini T. Transgenic SOD1 G93A mice develop reduced GLT-1 in spinal cord without alterations in cerebrospinal fluid glutamate levels. J. Neurochem. 2001, 79:737-746.
4. Bensimon G., Lacomblez L., Meininger V. A controlled trial of riluzole in amyotrophic lateral sclerosis. ALS/Riluzole Study Group. N. Engl. J. Med. 1994, 330:585-591.
5. Beretta S., Sala G., Mattavelli L., Ceresa C., Casciati A., Ferri A., Carri M.T., Ferrarese C. Mitochondrial dysfunction due to mutant copper/zinc superoxide dismutase associated with amyotrophic lateral sclerosis is reversed by N-acetylcysteine. Neurobiol. Dis. 2003, 13:213-221.
6. Bogdanov M.B., Ramos L.E., Xu Z., Beal M.F. Elevated "hydroxyl radical" generation in vivo in an animal model of amyotrophic lateral sclerosis. J. Neurochem. 1998, 71:1321-1324.
7. Boston-Howes W., Gibb S.L., Williams E.O., Pasinelli P., Brown R.H., Trotti D. Caspase-3 cleaves and inactivates the glutamate transporter EAAT2. J. Biol. Chem. 2006, 281:14076-14084.
8. Bowling A.C., Schulz J.B., Brown R.H., Beal M.F. Superoxide dismutase activity, oxidative damage, and mitochondrial energy metabolism in familial and sporadic amyotrophic lateral sclerosis. J. Neurochem. 1993, 61:2322-2325.
9. Canton T., Pratt J., Stutzmann J.M., Imperato A., Boireau A. Glutamate uptake is decreased tardively in the spinal cord of FALS mice. Neuroreport 1998, 9:775-778.
10. Carriedo S.G., Yin H.Z., Weiss J.H. Motor neurons are selectively vulnerable to AMPA/kainate receptor-mediated injury in vitro. J. Neurosci. 1996, 16:4069-4079.
11. Chi L., Ke Y., Luo C., Gozal D., Liu R. Depletion of reduced glutathione enhances motor neuron degeneration in vitro and in vivo. Neuroscience 2007, 144:991-1003.
12. Dringen R., Hirrlinger J. Glutathione pathways in the brain. Biol. Chem. 2003, 384:505-516.
13. Dugan L.L., Gabrielsen J.K., Yu S.P., Lin T.S., Choi D.W. Buckminsterfullerenol free radical scavengers reduce excitotoxic and apoptotic death of cultured cortical neurons. Neurobiol. Dis. 1996, 3:129-135.
14. Dun Y., Mysona B., Van Ells T., Amarnath L., Ola M.S., Ganapathy V., Smith S.B. Expression of the cystine-glutamate exchanger (xc-) in retinal ganglion cells and regulation by nitric oxide and oxidative stress. Cell Tissue Res. 2006, 324:189-202.
15. Ferrante R.J., Browne S.E., Shinobu L.A., Bowling A.C., Baik M.J., MacGarvey U., Kowall N.W., Brown R.H., Beal M.F. Evidence of increased oxidative damage in both sporadic and familial amyotrophic lateral sclerosis. J. Neurochem. 1997, 69:2064-2074.
16. Fogal B., Li J., Lobner D., McCullough L.D., Hewett S.J. System x(c)- activity and astrocytes are necessary for interleukin-1 beta-mediated hypoxic neuronal injury. J. Neurosci. 2007, 27:10094-10105.
17. Globus M.Y.-T., Alonso O., Dietrich W.D., Busto R., Ginsberg M.D. Glutamate release and free radical production following brain injury: effects of posttraumatic hypothermia. J. Neurochem. 1995, 65:1704-1711.
18. Gurney M.E., Pu H., Chiu A.Y., Dal Canto M.C., Polchow C.Y., Alexander D.D., Caliendo J., Hentati A., Kwon Y.W., Deng H.X. Motor neuron degeneration in mice that express a human Cu, Zn superoxide dismutase mutation. Science 1994, 264:1772-1775.
19. Howland D.S., Liu J., She Y., Goad B., Maragakis N.J., Kim B., Erickson J., Kulik J., DeVito L., Psaltis G., DeGennaro L.J., Cleveland D.W., Rothstein J.D. Focal loss of the glutamate transporter EAAT2 in a transgenic rat model of SOD1 mutant-mediated amyotrophic lateral sclerosis (ALS). Proc. Natl. Acad. Sci. U. S. A. 2002, 99:1604-1609.
20. Jaarsma D., Guchelaar H.J., Haasdijk E., de Jong J.M., Holstege J.C. The antioxidant N-acetylcysteine does not delay disease onset and death in a transgenic mouse model of amyotrophic lateral sclerosis. Ann. Neurol. 1998, 44:293.
21. Jackman N.A., Uliasz T.F., Hewett J.A., Hewett S.J. Regulation of system x(c)(-)activity and expression in astrocytes by interleukin-1beta: implications for hypoxic neuronal injury. Glia 2010, 58:1806-1815.
22. Kim J.Y., Kanai Y., Chairoungdua A., Cha S.H., Matsuo H., Kim D.K., Inatomi J., Sawa H., Ida Y., Endou H. Human cystine/glutamate transporter: cDNA cloning and upregulation by oxidative stress in glioma cells. Biochim. Biophys. Acta 2001, 1512:335-344.
23. Liochev S.I. Reactive oxygen species and the free radical theory of aging. Free Radic. Biol. Med. 2013, 60:1-4.
24. Liu R., Althaus J.S., Ellerbrock B.R., Becker D.A., Gurney M.E. Enhanced oxygen radical production in a transgenic mouse model of familial amyotrophic lateral sclerosis. Ann. Neurol. 1998, 44:763-770.
25. Louwerse E.S., Weverling G.J., Bossuyt P.M., Meyjes F.E., de Jong J.M. Randomized, double-blind, controlled trial of acetylcysteine in amyotrophic lateral sclerosis. Arch. Neurol. 1995, 52:559-564.
26. Meikle A.D., Martin A.H. A rapid method for removal of the spinal cord. Stain. Technol. 1981, 56:235-237.
27. Miller R.G., Mitchell J.D., Lyon M., Moore D.H. Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND). Cochrane Database Syst. Rev. 2002, (2):CD001447.
28. Mysona B., Dun Y., Duplantier J., Ganapathy V., Smith S.B. Effects of hyperglycemia and oxidative stress on the glutamate transporters GLAST and system xc- in mouse retinal Muller glial cells. Cell Tissue Res. 2009, 335:477-488.
29. Pasinelli P., Houseweart M.K., Brown R.H., Cleveland D.W. Caspase-1 and -3 are sequentially activated in motor neuron death in Cu, Zn superoxide dismutase-mediated familial amyotrophic lateral sclerosis. Proc. Natl. Acad. Sci. 2000, 97:13901-13906.
30. Piani D., Fontana A. Involvement of the cystine transport system xc- in the macrophage-induced glutamate-dependent cytotoxicity to neurons. J. Immunol. 1994, 152:3578-3585.
31. Qin S., Colin C., Hinners I., Gervais A., Cheret C., Mallat M. System Xc- and apolipoprotein E expressed by microglia have opposite effects on the neurotoxicity of amyloid-beta peptide 1-40. J. Neurosci. 2006, 26:3345-3356.
32. Rothstein J.D., Van Kammen M., Levey A.I., Martin L.J., Kuncl R.W. Selective loss of glial glutamate transporter GLT-1 in amyotrophic lateral sclerosis. Ann. Neurol. 1995, 38:73-84.
33. Rothstein J.D., Tsai G., Kuncl R.W., Clawson L., Cornblath D.R., Drachman D.B., Pestronk A., Stauch B.L., Coyle J.T. Abnormal excitatory amino acid metabolism in amyotrophic lateral sclerosis. Ann. Neurol. 1990, 28:18-25.
34. Rush T., Liu X.Q., Hjelmhaug J., Lobner D. Mechanisms of chlorpyrifos and diazinon induced neurotoxicity in cortical culture. Neuroscience 2010, 166:899-906.
35. Shefner J.M., Reaume A.G., Flood D.G., Scott R.W., Kowall N.W., Ferrante R.J., Siwek D.F., Upton-Rice M., Brown R.H. Mice lacking cytosolic copper/zinc superoxide dismutase display a distinctive motor axonopathy. Neurology 1999, 53:1239-1246.
36. Shih A.Y., Johnson D.A., Wong G., Kraft A.D., Jiang L., Erb H., Johnson J.A., Murphy T.H. Coordinate regulation of glutathione biosynthesis and release by Nrf2-expressing glia potently protects neurons from oxidative stress. J. Neurosci. 2003, 23:3394-3406.
37. Spreux-Varoquaux O., Bensimon G., Lacomblez L., Salachas F., Pradat P.F., Le Forestier N., Marouan A., Dib M., Meininger V. Glutamate levels in cerebrospinal fluid in amyotrophic lateral sclerosis: a reappraisal using a new HPLC method with coulometric detection in a large cohort of patients. J. Neurol. Sci. 2002, 193:73-78.
38. Warita H., Manabe Y., Murakami T., Shiote M., Shiro Y., Hayashi T., Nagano I., Shoji M., Abe K. Tardive decrease of astrocytic glutamate transporter protein in transgenic mice with ALS-linked mutant SOD1. Neurol. Res. 2002, 24:577-581.
39. Yim M.B., Kang J.H., Yim H.S., Kwak H.S., Chock P.B., Stadtman E.R. A gain-of-function of an amyotrophic lateral sclerosis-associated Cu, Zn-superoxide dismutase mutant: an enhancement of free radical formation due to a decrease in Km for hydrogen peroxide. Proc. Natl. Acad. Sci. U. S. A. 1996, 93:5709-5714.
40. Zoccolella S., Beghi E., Palagano G., Fraddosio A., Guerra V., Samarelli V., Lepore V., Simone I.L., Lamberti P., Serlenga L., Logroscino G., SLAP registry Riluzole and amyotrophic lateral sclerosis survival: a population-based study in southern Italy. Eur. J. Neurol. 2007, 14:262-268.